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Abstract
We have isolated and functionally characterized an additional murine member of the organic-anion-transporting polypeptide (Oatp) family
of membrane transport proteins from mouse liver. The 3.6 kb cDNA insert contains an open reading frame of 2010 bp coding for a 670 amino
acid protein. Based on its amino acid identity of 88% to the rat Oatp2, it is considered the mouse Oatp2 orthologue. Functional expression in
Xenopus laevis oocytes demonstrated that mouse Oatp2 transports several general Oatp substrates such as estrone-3-sulfate,
dehydroepiandrosterone sulfate (DHEAS), ouabain and BQ-123 but hardly any taurocholate nor rocuronium or deltorphin II. The high-
affinity rat Oatp2 substrate digoxin is transported with a rather low affinity with an apparent Km value of 5.7 AM. Bromosulfophthalein
(BSP), a substrate not transported by the rat Oatp2, is transported very well by mouse Oatp2. Northern blot analysis demonstrated a
predominant expression in the liver with additional signals in kidney and brain. Using fluorescence in situ hybridization, the Oatp2 gene
(gene symbol Slc21a5) was mapped to chromosome 6G1–G3. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The liver plays an essential role in the elimination of a
wide variety of endogenous and exogenous compounds.
The first step in this hepatic elimination is uptake from the
portal blood across the sinusoidal membrane of hepatocytes.
Many uptake carriers have been cloned from rat and human
liver, among them several members of the organic anion
transporting polypeptide (rodent: Oatps; human: OATPs)
family of membrane transporters [1–8]. Oatps/OATPs,
which are classified within the SLC21A family of solute
transporters, mediate Na + -independent transport of bile
salts, bromosulfophthalein (BSP), steroid hormones and
their conjugates, thyroid hormones, cardiac glycosides,
linear and cyclic peptides, bulky organic cations and various
drugs [6,9]. In general, the substrate specificities of the
individual Oatps/OATPs overlap considerably, but unique
features such as a preference of Oatp1 (Slc21a1) for organic
anions, of Oatp2 (Slc21a5) for the cardiac glycoside digoxin
and of OATP-A (SLC21A3) for organic cations were dem-
onstrated [2,6,10]. Most Oatps are broadly expressed in
different organs such as liver, kidney and brain with the
exception of Oatp4 (Slc21a10), OATP-C (SLC21A6) and
OATP8 (SLC21A8), the expression of which seems to be
restricted to the liver [4,8,11]. Differences in substrate
specificity and tissue distribution make it difficult to assign
orthologous rat and human Oatps/OATPs [6]. Therefore, it
is important to clone the mouse Oatps and to identify their
chromosomal localization as the human–mouse synteny is
well established and thus possible human orthologues of
rodent Oatps can more easily be identified in the mouse. In
addition, the mouse offers the possibility to knock out
individual Oatp genes in order to assess the physiological
importance of these carriers.
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The first mouse orthologue to be cloned and character-
ized was Oatp1 [12]. Mouse Oatp1 is likely to be the
orthologue of rat Oatp1 because of similar substrate specif-
icities and tissue distributions, but its chromosomal local-
ization on the X chromosome is not syntenic with the
localization of any cloned human OATP [12]. In contrast,
mouse Oatp3 is localized on chromosome 6 [3], which is
syntenic with human chromosome 12p12 where several
human OATPs are located [8,13]. The chromosomal local-
ization of additional mouse Oatps has not been studied yet,
but this information is needed to clarify the relationship
between rodent and human Oatps/OATPs.
Recently, the cloning and molecular characterization of
mouse Oatp4 (lst-1) [14], mouse Oatp5 (Slc21a13) [15] and
mouse Oatp2 [16] were described by the same group.
Unfortunately, no functional data were reported so far for
any of the isolated proteins. Without demonstration of func-
tional transport, only speculations based on knowledge
derived from other species can be made about the potential
physiological role of the protein. However, with the option of
knockout mice, it is crucial to understand mouse physiology
and thus also to functionally characterize newly cloned
mouse Oatps. Therefore, we report here the isolation of a
functional mouse Oatp2, its molecular characterization, and
its chromosomal localization.
2. Materials and methods:
2.1. Animals
Female Xenopus laevis were purchased from the African
Xenopus facility c.c., Noordoek, R. South Africa.
2.2. Materials
[3H]Digoxin (703 GBq/mmol), [3H]oestrone-3-sulfate
(1.96 TBq/mmol), [3H]dehydroepiandrosterone sulfate
(DHEAS, 2.22 TBq/mmol), [3H]taurocholic acid (111
GBq/mmol), [3H]ouabain (610.5 GBq/mmol) and [3H] del-
torphin II (1.52 TBq/mmol) were obtained from NEN Life
Science Products AG (Boston, MA, USA). [3H] BQ-123
(1.33 TBq/mmol) and deoxycytidine 5V[a-32]triphosphate
(111 TBq/mmol) were obtained from Amersham Pharmacia
Biotech AB, Uppsala, Sweden. [14C]Rocuronium (54mCi/
mmol) was the kind gift of Organon International BV (Oss,
The Netherlands). [35S]-BSP (2.5 Ci/mmol) was synthesized
as described [17].
2.3. Isolation of the mouse Oatp2 cDNA clone and its
functional characterization in X. laevis oocytes
To isolate the mouse orthologues of the human OATP-A
[5], a hybridization probe was generated by RT-PCR using
mouse liver mRNA and OATP-A specific primers [12]. The
amplified product of 685 bp was 93% identical to the rat
Oatp2 cDNA [2] and successfully used to isolate the mouse
Oatp1 [12]. Primers derived from this cDNA (forward:5V-
CAGGAATGACCATTGGCCC-3V; reverse: 5V-CCTTGA-
TTTTTTCTCTGTGC-3V) were then used to screen a mouse
liver Rapid-Screen cDNA library panel (OriGene Technolo-
gies, Rockville, MD, USA) by PCR. This resulted in the
isolation of a single cDNA clone that represented mouse
Oatp2 but was missing the first 70 amino acids. Using
5VRACE, the missing cDNA was obtained, cloned and
sequenced. To obtain the full-length mouse Oatp2 cDNA,
the two overlapping fragments were individually PCR ampli-
fied using the proofreading enzyme TurboPfu (Stratagene, La
Jolla, CA, USA). After gel purification, these two fragments
were used as a template for another PCR with the flanking
primers and one long fragment was obtained and cloned
into the pUC19 vector. Sequencing revealed that the
resulting cDNA insert had a unique NotI site at its 3V end
(from the original pCMV6-XL4 vector) and a unique SalI
site at its 5V end (from the pUC19 vector) and therefore
could be directionally sub-cloned into the NotI/SalI cut
pSPORT1. Given the low error rate of TurboPfu, we only
worked with one independently isolated clone that was
sequenced on both strands using an ALFexpress (Amer-
sham Pharmacia Biotech) and used for all subsequent
experiments.
For in vitro synthesis of cRNA, the cDNA clone was
linearized with NotI and capped cRNA was synthesized
using the mMESSAGE mMACHINE T7 kit (Ambion,
Austin, TX, USA). X. laevis oocytes were prepared and
handled as described previously [18] and after an over-
night incubation at 18 jC, healthy oocytes were injected
with 5 ng of Oatp2 cRNA. After 2–3 days in culture,
uptake of the indicated substrates was measured at 25 jC
in a medium containing 100 mM choline chloride, 2 mM
KCl, 1 mM CaCl2, 1 mM MgCl2 and 10 mM Hepes/Tris,
pH 7.5, as described previously [19].
2.4. Northern blot analysis
A commercially available Northern Blot (ClonTech, Palo
Alto, CA, USA) was prehybridized for 30 min at 55 jC in
ExpressHyb hybridization solution and then hybridized for
60 min at 55 jC with a PCR amplified 32P-labelled mouse
Oatp2 cDNA probe (nts 611–1276 of AB031814). The blot
was washed twice for 5 min at room temperature with 2
standard saline citrate (SSC)/0.1% SDS, followed by 15 min
at 45 jC with 0.1 SSC/0.1% SDS. The blot was then
exposed to autoradiography film at  70 jC overnight. To
confirm equal loading, the blot was hybridized with a
human h-actin probe as a control.
2.5. Fluorescence in situ hybridization analysis (FISH)
FISH was performed as described previously [12]. The
Oatp2 containing BAC clone was labelled using the Gibco
Nick Translation System with digoxigenin-dUTP (Roche
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Diagnostics, Germany), while the chromosome 6 painting-
probe (Cambio, Cambridge) was labelled with biotin-16-
dUTP.
3. Results and discussion
3.1. Isolation and characterization of cDNA and amino acid
sequence
To functionally characterize the mouse orthologue of the
rat Oatp2 [2], we isolated a cDNA clone of 3634 bp
including a poly(A) tail of 28 nucleotides. This cDNA insert
consisted of 67 bp of 5Vuntranslated sequence followed by
2010 bp of open reading frame and 1557 bp of 3Vuntrans-
lated sequence. A closer inspection of the short 5Vuntrans-
lated region revealed that it started almost at the end of exon
3 and contained, similar to one of the published mouse
Oatp2 clones [16], an additional 4-bp sequence (ACAG)
between exon 3 and exon 4. The open reading frame
encoded a protein of 670 amino acids with a calculated
molecular mass of 73899 Da (Fig. 1). The coding region of
this cDNA clone isolated form a Swiss Webster mouse liver
library was nearly identical to the cDNA isolated from a
BALB/c library (GenBank accession number AB031814
[16]). There were 12 nucleotide changes that resulted in
eight amino acid replacements: I301V (AB031814 amino
acid residue listed first), G391A, E398D, P428S, D438N,
D501N, E505D and T552A. These differences are most
likely due to the different mouse strains used to isolate the
cDNAs. Interestingly, five of the eight amino acid residues
of the BALB/c sequence are identical to the mouse Oatp1
amino acid sequence. However, since there is no functional
data available for the BALB/c sequence [16], we only can
speculate that such amino acid changes would not change
the substrate specificity of the transport protein. Compar-
isons of the available amino acid sequences revealed 80%,
98%, 83%, 40% and 44% identity to mouse Oatp1
(AF148218, gene symbol Slc21a1), Oatp2 (AB031814,
Slc21a5), Oatp3 (AF240694, Slc21a7), Oatp4 (AJ271682,
Slc21a10) and Oatp14 (also called organic anion transporter
2, AY007379, Slc21a14). Highest amino acid sequence
identities to human OATPs were found to be 72%, 43%,
43% and 44% to Oatp-A (U21943, SLC21A3), OATP-C
(AB026257, SLC21A6), OATP8 (AJ251506, SLC21A8) and
OATP-F (AF260704, SLC21A14), respectively.
The alignment of the amino acid sequences of mouse
Oatp2 with its rat orthologue Oatp2 and its closest mouse
relatives Oatp1 and Oatp3 is shown in Fig. 1. Two major
differences exist between mouse and rat Oatp2. In contrast
to rat Oatp2, the mouse protein does not have an amino acid
deletion at position 117 and the C terminal end of mouse
Oatp2 corresponds more to the sequences of Oapt1 and
Oatp3. Thus, all mouse clones are composed of 670 amino
acids, whereas rat Oatp2 contains only 661 amino acids.
Whether these findings could have implications for the
substrate specificity of mouse, Oatp2 was tested with a
series of typical Oatp substrates in X. laevis oocytes.
3.2. Functional characterization of mouse Oatp2 in X.
laevis oocytes
Although the members of the Oatp family have broad
and overlapping substrate specificities, organic anions such
as BSP and the opioid peptide deltorphin II were identified
as preferred substrates of rat Oatp1, whereas the cardiac
glycoside digoxin and bulky organic cations such as rocuro-
nium are more specific for rat Oatp2 [2,10,20,21]. In a
substrate comparison, mouse Oatp1 showed the same sub-
strate specificity as rat Oatp1 [12]. Table 1 summarizes the
transport rates of various substrates determined in mouse
Oatp2 cRNA-injected oocytes. Thereby, digoxin and BQ-
123 showed the highest transport rates. Ouabain, BSP,
estrone-3-sulfate and DHEAS were also identified as sub-
strates for mouse Oatp2, while taurocholate, deltorphin II
and rocuronium were hardly or not transported at all. Rat
and mouse Oatp2 share the unique feature of digoxin
transport, but surprisingly mouse Oatp2 also transported
BSP, which is not a substrate of rat Oatp2 [1]. Furthermore,
mouse Oatp2 did not transport rocuronium, which is an
additional difference between rat and mouse Oatp2 [21].
These differences in the substrate specificities of rat and
mouse Oatp2 emphasize the importance of the functional
characterization of orthologous gene products since func-
tional predictions that are based on protein homologies
could be misleading.
Since the binding sites of rat and mouse Oatp2 have not
been identified yet, it is tempting to speculate that the
additional amino acid at position 117 and/or the different
C terminal end compared to rat Oatp2 might be involved in
BSP transport and the absence of rocuronium uptake by
mouse Oatp2.
As differences in the substrate specificity between rat and
mouse Oatp2 were found, transport of the typical Oatp2
substrate digoxin was further investigated. As depicted in
Fig. 2, digoxin uptake by mouse Oatp2 was saturable and
yielded an apparent Km value of 5.7 AM. The affinity of
mouse Oatp2 for digoxin is much lower than the affinity of
rat Oatp2 for which an apparent Km value of 0.24 AM was
reported [2]. Thus, rat and mouse Oatp2 differ not only in
their substrate specificity, but also in their affinity for
digoxin.
3.3. Tissue distribution of mouse Oatp2
The tissue distribution of mouse Oatp2 was determined
by Northern blot analysis using a cDNA probe derived from
the open reading frame of the transporter. As shown in Fig.
3, the strongest signal was obtained in liver and weaker
signals in kidney and brain. Several transcript sizes were
detected in liver and kidney, whereas in brain a single band
of 4.4 kb was found. The signals in the liver and brain are in
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Fig. 1. Amino acid alignment of mouse Oatp2 (mOatp2), rat Oatp2 (rOatp2) mouse Oatp3 (mOatp3) and mouse Oatp1 (mOatp1). Amino acids identical in all four proteins are boxed in black, amino acids identical
in three proteins are boxed in dark grey while amino acids identical in only two of the proteins are boxed in light grey. The twelve putative transmembrane domains are indicated with lines.
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accordance with the results of Ogura et all. [16]. However,
since the hybridization probe that was used in this study has
a high identity to other Oatps (e.g. Oatp1, Oatp3 and
Oatp5), the signal obtained for the kidney could be due to
cross-hybridization with an Oatp that is highly expressed in
this tissue. Therefore, real-time PCR experiments with
Oatp2-specific primers were performed and demonstrated
that Oatp2 levels in the kidney were less than 0.5% of the
expression in the liver (data not shown). Thus, the kidney
signal obtained on the Northern blot might represent expres-
sion of another Oatp. In contrast to Ogura et al. [16] who
detected a mouse Oatp2 transcript also in heart and lung,
even after a 48 h exposure of the blot, no signal was
detected in heart, spleen, lung, skeletal muscle and testis
in this study (not shown). While Ogura et al. [16] used a
probe derived from exon 3 located in the 5V untranslated
region, we used a probe derived from the protein coding
region of Oatp2. As only the exon 3 probe gave a signal in
heart and lung, it is not very likely that mouse Oatp2 plays a
role in digoxin transport in the heart. The mRNA distribu-
tion of mouse Oatp2 is therefore in accordance with the
mRNA distribution of rat Oatp2, which was also found to be
expressed in liver, kidney and brain [2].
3.4. Chromosomal localization of mouse Oatp2
Finally, the chromosomal localization of mouse Oatp2
was determined by FISH. As demonstrated in Fig. 4, the
mouse Oatp2 gene was localized to chromosome 6 at locus
6G1–G3. In addition, searching NCBIs UniSTS, a resource
that reports information about markers or sequence tagged
sites (STS), we could locate the mouse Oatp2 gene with the
radiation hybrid (RH) marker 617897 close to the location
of mouse Oatp3 (Slc21a7) (RH D6Mit58) [3], mouse Oatp5
Fig. 4. Chromosomal mapping of the mouse Oatp2 gene to chromosome
6G1–G3. A two-colour FISH analysis was performed with the Oatp2 probe
(green signal) and a chromosome 6 painting probe (red signal). Where the
two signals are superimposed, a yellow signal is observed and the green
signal is no longer visible.
Table 1
Substrate specificity of mouse Oatp2 in X. laevis oocytes
Substrate Uptake
mOatp2 Ratio
Digoxin (0.5 AM) 246F 56 13.7
BQ-123 (0.67 AM) 3F 0.8 10
BSP (2 AM) 645F 128 4.6
DHEAS (0.2 AM) 14F 2.4 3.7
Estrone-3-sulfate (0.5 AM) 43F 7 3.3
Ouabain (2.4 AM) 40F 6 2.7
Taurocholate (5 AM) 188F 60 1.5
Rocuronium (10 AM) 1120F 180 1.3
Deltorphin II (0.2 AM) 11F1.4 0.9
Values represent meansF S.D. of 9 to 12 determinations and are given in
femtomoles per oocyte. Ratios correspond to uptake in cRNA-injected
oocytes divided by uptake in water-injected control oocytes. X. laevis
oocytes were injected with 5 ng of mouse Oatp2 cRNA, and after 3 days in
culture, uptake of the indicated substrates was measured for 30 min.
Fig. 3. Northern blot analysis of the tissue distribution of Oatp2. A
commercially available blot (ClonTech) containing 2 Ag of mRNA from
different tissues per lane was hybridized with an Oatp2-specific cDNA
probe as described in Materials and methods. Molecular size standards are
indicated on the left.
Fig. 2. Kinetics of Oatp2-mediated digoxin uptake into X. laevis oocytes.
Oocytes were injected with 5 ng of Oatp2-cRNA (.) or with 50 nl of water
(o) and after 3 days in culture, initial (10 min) uptake of [3H]digoxin
uptake was performed in the presence of increasing digoxin concentrations
at 25 jC. The values represent meansF S.E. of 9–12 determinations. After
subtracting the values of the water-injected oocytes, the data were fitted by
nonlinear regression analysis to the Michaelis–Menten equation and
plotted as a line.
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(Slc21a13, RH 622831) and Oatp14, the mouse orthologue
of human OATP-F (close to RH 662222). This region is
syntenic with human chromosome 12p12 where a cluster of
human OATP (SLC21A) genes is located, which includes
OATP-A, OATP-C, OATP8 [8,13] and OATP-F (SLC21A14)
[22]. Thus, similar to this human OATP gene subfamily,
there seems to exist a mouse subfamily, which, given its
clustered occurrence on chromosome 6, most likely arose
through several gene duplications. The mouse Oatp1 gene is
so far the only Oatp gene in this closely related group of
membrane transporters that is not located on chromosome 6
but localized to XA3–A5 [12]. Based on the amino acid
identity, OATP-A is the most closely related human OATP
on chromosome 12 for all, mouse Oatp1, Oatp2, Oatp3 and
Oatp5. This could be explained by gene duplications in
rodents after they diverged from primates, and makes it
impossible to determine the true orthologues transport
systems in rodents for human OATP-A. These findings
stress once more that for certain gene products, the inter-
species correlations are far from evident and that it is
absolutely necessary to functionally characterize transport
proteins before conclusions from animal models are adopted
for other species.
In conclusion, we have isolated and functionally charac-
terized mouse Oatp2. It is very likely the orthologue of rat
Oatp2 because of its high amino acid identity and its similar
substrate specificity and tissue distribution. However, some
differences between mouse and rat Oatp2 were found such
as, e.g. the ability to mediate BSP transport and a much
lower digoxin affinity of mouse Oatp2, which can be
explained by subtle differences in the amino acid sequence
(e.g. an amino acid deletion in rat Oatp2 at position 117 or
the different C terminal ends). The mouse Oatp2 gene was
localized to chromosome 6, which is syntenic with human
chromosome 12. The identification of the gene cluster on
mouse chromosome 6 explains that several rodent Oatps
have a high amino acid identity to one single human OATP,
OATP-A, if the gene duplication in rodents occurred after
speciation.
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